ESC Premium Access

State of the Art: oral anticoagulation in the challenging patient

Congress Session

About the speaker

Professor Paulus Kirchhof

University Heart & Vascular Center Hamburg, Hamburg (Germany)
43 presentations
1 follower

4 more presentations in this session

Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors

Speaker: Doctor J. Michel (Austin, US)

Thumbnail

Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Thumbnail

The future of oral anticoagulation

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Access the full session

How to make oral anticoagulation safe

Speakers: Professor P. Kirchhof, Doctor M. Proietti, Doctor J. Michel, Doctor M. Esteve Pastor, Doctor J. Weitz
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk